Successful treatment with immunosuppression, anticoagulation and vasodilator therapy of pulmonary hypertension in SLE associated with secondary antiphospholipid syndrome

Lupus

Volumn 7, Issue 7, 1998, Pages 495-497

  Tam, L S ^a   Li, E K ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Antiphospholipid syndrome; Pulmonary hypertension; SLE

Indexed keywords

ANTICOAGULANT AGENT; CYCLOPHOSPHAMIDE; DILTIAZEM; IMMUNOSUPPRESSIVE AGENT; PHOSPHOLIPID ANTIBODY; PREDNISONE; VASODILATOR AGENT; WARFARIN;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CASE REPORT; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME;

ADULT; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; CYCLOPHOSPHAMIDE; DILTIAZEM; FEMALE; HUMANS; HYPERTENSION, PULMONARY; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREDNISONE; VASODILATOR AGENTS; WARFARIN;

EID: 0031719888     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/096120398678920442     Document Type: Article

References (14)

1. Asherson RA et al Pulmonary hypertension in systemic lupus erythematosus BMJ 1983; 287: 1024-1025.
2. Asherson RA et al. Pulmonary hypertension in a lupus clinic Experience with twenty-four patients. J Rheumatol 1990; 17: 12921298.
3. th ed) William & Wilkins Baltimore. MD, 1997; 673-692.
4. Winslow TM et al Five-year follow-up study of the prevalence and progression of pulmonary hypertension in systemic lupus erythematosus Am Heart J 1995; 129: 510-515
5. Rich S, Kaufmann E, Levy PS. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension N Engl J Med 1992; 327: 76-81
6. Shmohara S et al. Combined effects of diltiazem and oxygen in pulmonary hypertension of mixed connective tissue disease J Rheumatol 1994; 21: 1763-1765.
7. Fuster V et al. Primary pulmonary hypertension: nature history and the importance of thrombosis. Circulation 1984; 70: 580-587
8. Sandoval J et al. Primary antiphospholipid syndrome presenting as chronic thromboembolic pulmonary hypertension. Treatment with thromboendarterectomy J Rheumatol 1996; 23: 772 -775
9. Menon N, McAlpine L, Peacock AJ, Madhok R The acute effects of prostacyclin on pulmonary hemodynamics in patients with pulmonary hypertension secondary to systemic sclerosis. Arthritis Rheum 1998; 41: 466-469.
10. Goupille P et al. Precapillary pulmonary hypertension dramatically improved with high doses of corticosteroids during systemic lupus erythematosus. J Rheumatol 1994; 21: 10
11. Groen H, Bootsma H, Postma DS, Kallenberg CGM Primary pulmonary hypertension in a patient with SLE. partial improvement with cyclophosphamide. J Rheumatol 1993; 20: 1055-1057
12. Karmochkine M et al Improvement of severe pulmonary hypertension in a patient with systemic lupus erythematosus. Ann Rheum Dis 1996; 55: 561-562.
13. 1 J Rheumatol 1993; 20: 595-596.
14. Morelli S et al. Pulmonary arterial hypertension responsive to immunosuppressive therapy in systemic lupus erythematosus Lupus 1993; 2: 367-369